Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
3.150
+0.010 (0.32%)
Jul 11, 2025, 9:36 AM - Market open

Anixa Biosciences Market Cap

Anixa Biosciences has a market cap or net worth of $101.46 million as of July 11, 2025. Its market cap has increased by 26.83% in one year.

Market Cap
101.46M
Enterprise Value
85.77M
1-Year Change
26.83%
Ranking
Category
Stock Price
$3.15

Market Cap Chart

Since December 1, 1998, Anixa Biosciences's market cap has increased from $83.20M to $101.46M, an increase of 21.95%. That is a compound annual growth rate of 0.75%.

History

DateMarket Cap% Change
Jul 10, 2025 101.10M 35.34%
Dec 31, 2024 74.70M -38.06%
Dec 29, 2023 120.60M -7.44%
Dec 30, 2022 130.30M 46.40%
Dec 31, 2021 89.00M 21.92%
Dec 31, 2020 73.00M 10.11%
Dec 31, 2019 66.30M -10.04%
Dec 31, 2018 73.70M 106.44%
Dec 29, 2017 35.70M -24.52%
Dec 30, 2016 47.30M 79.85%
Dec 31, 2015 26.30M 10.04%
Dec 31, 2014 23.90M -39.34%
Dec 31, 2013 39.40M 18.32%
Dec 31, 2012 33.30M 73.44%
Dec 30, 2011 19.20M -39.81%
Dec 31, 2010 31.90M -65.14%
Dec 31, 2009 91.50M 61.95%
Dec 31, 2008 56.50M -63.00%
Dec 31, 2007 152.70M 62.27%
Dec 29, 2006 94.10M 31.24%
Dec 30, 2005 71.70M -0.42%
Dec 31, 2004 72.00M 94.07%
Dec 31, 2003 37.10M 183.21%
Dec 31, 2002 13.10M -52.88%
Dec 31, 2001 27.80M -35.94%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 709.79B
Johnson & Johnson 379.41B
AbbVie 344.45B
Novo Nordisk 316.64B
UnitedHealth Group 271.70B
Novartis AG 243.81B
Abbott Laboratories 232.44B
AstraZeneca 223.49B
Market Cap Rankings